PAK1 and cardiac hypertrophy: At the same time, the administration of the ERK1/2 selective inhibitor FR180204 reduced the ERK1/2 phosphorylation and LV myocardial hypertrophy in ISO-treated WT and Pak-1-knockout (KO) mice [75].